- Home
- AUPH vs VHI Comparison
AUPH vs VHI Comparison
Compare AUPH & VHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- VHI
- Stock Information
- Founded
- AUPH 1993
- VHI 1932
- Country
- AUPH Canada
- VHI United States
- Employees
- AUPH N/A
- VHI N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- VHI Major Chemicals
- Sector
- AUPH Health Care
- VHI Industrials
- Exchange
- AUPH Nasdaq
- VHI Nasdaq
- Market Cap
- AUPH 1.0B
- VHI 1.2B
- IPO Year
- AUPH 1999
- VHI N/A
- Fundamental
- Price
- AUPH $8.12
- VHI $24.14
- Analyst Decision
- AUPH Strong Buy
- VHI Sell
- Analyst Count
- AUPH 3
- VHI 1
- Target Price
- AUPH $10.33
- VHI $20.00
- AVG Volume (30 Days)
- AUPH 1.3M
- VHI 40.5K
- Earning Date
- AUPH 11-07-2024
- VHI 11-07-2024
- Dividend Yield
- AUPH N/A
- VHI 1.33%
- EPS Growth
- AUPH N/A
- VHI N/A
- EPS
- AUPH N/A
- VHI 3.08
- Revenue
- AUPH $220,361,000.00
- VHI $2,076,900,000.00
- Revenue This Year
- AUPH $36.52
- VHI $19.58
- Revenue Next Year
- AUPH $19.02
- VHI $11.92
- P/E Ratio
- AUPH N/A
- VHI $7.82
- Revenue Growth
- AUPH 38.72
- VHI 10.99
- 52 Week Low
- AUPH $4.71
- VHI $12.12
- 52 Week High
- AUPH $10.05
- VHI $41.75
- Technical
- Relative Strength Index (RSI)
- AUPH 62.64
- VHI 32.74
- Support Level
- AUPH $8.06
- VHI $33.01
- Resistance Level
- AUPH $8.70
- VHI $41.75
- Average True Range (ATR)
- AUPH 0.34
- VHI 2.83
- MACD
- AUPH 0.07
- VHI -1.60
- Stochastic Oscillator
- AUPH 63.74
- VHI 10.47
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing LUPKYNIS (voclosporin), an investigational drug, for the treatment of lupus nephritis (LN), and others. Geographically, it derives maximum revenue from the United States.
About VHI Valhi Inc.
Valhi Inc is a holding company that provides chemicals, security products, waste management systems, and real estate development and management through its subsidiaries. It operates its business in three segments, which are Chemicals, Component Products, and Real Estate Management and Development. The company derives maximum revenue from the Chemicals segment. Chemicals Segment is a producer and marketer of value-added titanium dioxide pigments (TiO2). TiO2 is used to impart whiteness, brightness, opacity, and durability to a wide variety of products, including paints, plastics, paper, fibers, and ceramics. Geographically the company operates in the United States, Germany, Canada, Norway, and Belgium, where the majority of revenue comes from the United States.